The U.S. health care system is unique, but some observers say what makes it truly distinct from other health care systems around the globe is the amount patients—including those who are insured—pay out of pocket for care.
Federal and state officials last week raided a plastic surgery office following accusations that a doctor at the clinic administered non-FDA-approved drugs to patients who purchased certain services through Groupon, adding to growing concerns that Groupon users might be more vulnerable to medical scams.
A federal judge on Tuesday vacated HHS' site-neutral payment policy that cuts Medicare payment rates for off-campus hospital facilities.
An FDA advisory panel this month recommended approval of an experimental treatment for peanut allergies but, writing in The Atlantic, James Hamblin questions whether the product is worth its likely $4,200 price tag—and flags research suggesting it might backfire for some patients.
Some air ambulance companies are selling membership subscriptions that promise patients will pay no out-of-pocket costs if they use the transportation services, but state regulators—and some larger air ambulance companies—are skeptical of the memberships' no-cost guarantee.